Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
alnylam pharmaceuticals
amgen
biotech
1
×
boston blog main
boston top stories
clinical trials
deals
evolocumab
1
×
fda
inclisiran
life sciences
national blog main
national top stories
new york
new york blog main
1
×
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
the medicines company
What
acquire
agreed
billion
brings
cash
cholesterol
company
compound
1
×
deal
drug
fda
medco
medicines
new
novartis
poised
1
×
ready
1
×
wave
Language
unset
Current search:
evolocumab
×
ready
×
poised
×
biotech
×
" new york blog main "
×
compound
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B